Clinical Trial

Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals

Study acronym: MG3
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 11, 2025 (before its estimated April 13, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to investigate the effect of mango intake on metabolic and inflammatory responses relative to meals in individuals at risk of developing diabetes, as well as to understand how the beneficial compounds found in mangoes are absorbed and processed in the body.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-20.
Status change: Active, Not Recruiting → Recruiting 2025-07-10
Trial Details
NCT Number NCT06986161
Lead Sponsor Clinical Nutrition Research Center, Illinois Institute of Technology
Collaborators: National Mango Board
Conditions Pre Diabetes
Enrollment 30 participants
Start Date 2025-04-14
Primary Completion 2026-04-13 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-11